https://www.selleckchem.com/products/AZD0530.html
001). In patients with PE (48/151, 31.8%), lobar PBV was 12.6% (IQR 9.6-15.7%), 13.7% (IQR 10.1-16.7%) and 6.5% (IQR 5.1-10.2%) in the lobes with CTOI =0, low CTOI and high CTOI scores, respectively, with a significantly decreased PBV in the lobes with high CTOI score ( .001). ROC analysis of lobar PBV for prediction of high CTOI score revealed AUC of 0.847 (95%CI 0.785-0.908). Pulmonary perfusion was heterogeneously distributed along the pulmonary lobes in patients without cardiopulmonary diseases. In patients with PE, the lobes wi